NFKB1 and Parkinson disease: The immunomodulatory effect of retinoic acid is carried out via inactivation of receptor-advanced glycation-end (RAGE) products, key regulators of p38 mitogen-activated protein kinase/nuclear factor kappa B (p38MAPK/NF-κB)-associated inflammatory cytokine production during PD [23].